Molecular virology of hepatitis e virus

Seminars in Liver Disease

Volumn 33, Issue 1, 2013, Pages 3-14

  Holla, R Prasida ^a   Ahmad, Imran ^a   Ahmad, Zulfazal ^a   Jameel, Shahid ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

Author keywords

hepatitis E; HEV; ORF1; ORF2; ORF3; RNA replication

Indexed keywords

METHYLTRANSFERASE; PROLINE; PROTEINASE; RNA DIRECTED RNA POLYMERASE; RNA HELICASE; VIRUS PROTEIN;

ARTICLE; GENETIC VARIABILITY; HEPATITIS C VIRUS; HEPATITIS E; HUMAN; IN VITRO STUDY; LIFE CYCLE STAGE; MOLECULAR VIROLOGY; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; REPLICON; VIROLOGY; VIRUS GENOME; VIRUS LIFE CYCLE; VIRUS REPLICATION;

GENOME, VIRAL; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; VIRAL PROTEINS;

EID: 84876006722     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0033-1338110     Document Type: Article

References (129)

1. Emerson S. U., Purcell R. H. Hepatitis E virus. In: Knipe D. M., Howley P. M., Griffin D. E., Lamb R. A., Martin M. A., Roizman B., Straus S. E., eds. Fields Virology. 5th ed. Philadelphia Lippincott Williams & Wilkins: 2006; 3047-3058
2. Hepatitis E. Media Centre, World Health Organization. 2012. Available at: http://www.who.int/mediacentre/factsheets/fs280/en/. Accessed October 15, 2012
3. Khuroo M. S. Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. Virus Res: 2011; 161 1 3 14
4. Meng X. J., Anderson D., Arankalle V. A., et al. Hepeviridae. In: King A. MQ, Adams M. J., Carstens E. B., Lefkowitz E. J., eds. Virus Taxonomy, Ninth Report of the International Committee on Taxonomy of Viruses. Oxford Elsevier/Academic Press: 2011; 1021 1028
5. Okamoto H. Genetic variability and evolution of hepatitis E virus. Virus Res: 2007; 127 2 216 228
6. Uchida T., Suzuki K., Iida F., et al. Animal model, virology and gene cloning of hepatitis E. Gastroenterol Jpn: 1991; 26 03 148 151
7. Ticehurst J., Rhodes L. L. Jr, Krawczynski K., et al. Infection of owl monkeys (Aotus trivirgatus) and cynomolgus monkeys (Macaca fascicularis) with hepatitis E virus from Mexico. J Infect Dis: 1992; 165 5 835 845
8. McCaustland K. A., Krawczynski K., Ebert J. W., et al. Hepatitis E virus infection in chimpanzees: a retrospective analysis. Arch Virol: 2000; 145 9 1909 1918
9. Meng X. J., Halbur P. G., Haynes J. S., et al. Experimental infection of pigs with the newly identified swine hepatitis E virus (swine HEV), but not with human strains of HEV. Arch Virol: 1998; 143 7 1405 1415
10. Viswanathan R. Infectious hepatitis in Delhi (1955-56) A critical study: epidemiology. Indian J Med Res: 1957; 45 01 1 29
11. Khuroo M. S. Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. Virus Res: 2011; 161 1 3 14
12. Balayan M. S., Andjaparidze A. G., Savinskaya S. S., et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology: 1983; 20 1 23 31
13. Velázquez O., Stetler H. C., Avila C., et al. Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986-1987. JAMA: 1990; 263 24 3281 3285
14. Zhuang H., Cao X. Y., Liu C. B., Wang G. M. Epidemiology of hepatitis E in China. Gastroenterol Jpn: 1991; 26 03 135 138
15. Naik S. R., Aggarwal R., Salunke P. N., Mehrotra N. N. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ: 1992; 70 5 597 604
16. Teshale E. H., Howard C. M., Grytdal S. P., et al. Hepatitis E epidemic, Uganda. Emerg Infect Dis: 2010; 16 1 126 129
17. Nicand E., Armstrong G. L., Enouf V., et al. Genetic heterogeneity of hepatitis E virus in Darfur, Sudan, and neighboring Chad. J Med Virol: 2005; 77 4 519 521
18. Tam A. W., Smith M. M., Guerra M. E., et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology: 1991; 185 1 120 131
19. Reyes G. R., Huang C. C., Tam A. W., Purdy M. A. Molecular organization and replication of hepatitis E virus (HEV). Arch Virol Suppl: 1993; 7 15 25
20. Ahmad I., Holla R. P., Jameel S. Molecular virology of hepatitis E virus. Virus Res: 2011; 161 1 47 58
21. Reyes G. R., Purdy M. A., Kim J. P., et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science: 1990; 247 4948 1335 1339
22. Huang C. C., Nguyen D., Fernandez J., et al. Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology: 1992; 191 2 550 558
23. Panda S. K., Ansari I. H., Durgapal H., Agrawal S., Jameel S. The in vitro-synthesized RNA from a cDNA clone of hepatitis E virus is infectious. J Virol: 2000; 74 5 2430 2437
24. Emerson S. U., Zhang M., Meng X. J., et al. Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cis-reactive element. Proc Natl Acad Sci U S A: 2001; 98 26 15270 15275
25. Graff J., Torian U., Nguyen H., Emerson S. U. A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus. J Virol: 2006; 80 12 5919 5926
26. Huang Y. W., Opriessnig T., Halbur P. G., Meng X. J. Initiation at the third in-frame AUG codon of open reading frame 3 of the hepatitis E virus is essential for viral infectivity in vivo. J Virol: 2007; 81 6 3018 3026
27. Ichiyama K., Yamada K., Tanaka T., et al. Determination of the 5′-terminal sequence of subgenomic RNA of hepatitis E virus strains in cultured cells. Arch Virol: 2009; 154 12 1945 1951
28. Pelosi E., Clarke I. Hepatitis E: a complex and global disease. Emerg Health Threats J: 2008; 1 e8
29. Haqshenas G., Shivaprasad H. L., Woolcock P. R., Read D. H., Meng X. J. Genetic identification and characterization of a novel virus related to human hepatitis E virus from chickens with hepatitis-splenomegaly syndrome in the United States. J Gen Virol: 2001; 82 Pt 10 2449 2462
30. Huang F. F., Sun Z. F., Emerson S. U., et al. Determination and analysis of the complete genomic sequence of avian hepatitis E virus (avian HEV) and attempts to infect rhesus monkeys with avian HEV. J Gen Virol: 2004; 85 Pt 6 1609 1618
31. Johne R., Heckel G., Plenge-Bönig A., et al. Novel hepatitis E virus genotype in Norway rats, Germany. Emerg Infect Dis: 2010; 16 9 1452 1455
32. Raj V. S., Smits S. L., Pas S. D., et al. Novel hepatitis E virus in ferrets, the Netherlands. Emerg Infect Dis: 2012; 18 8 1369 1370
33. Zhao C., Ma Z., Harrison T. J., et al. A novel genotype of hepatitis E virus prevalent among farmed rabbits in China. J Med Virol: 2009; 81 8 1371 1379
34. Jirintai S., Jinshan, Tanggis, et al. Molecular analysis of hepatitis E virus from farm rabbits in Inner Mongolia, China and its successful propagation in A549 and PLC/PRF/5 cells. Virus Res: 2012; 170 1-2 126 137
35. Batts W., Yun S., Hedrick R., Winton J. A novel member of the family Hepeviridae from cutthroat trout (Oncorhynchus clarkii). Virus Res: 2011; 158 1-2 116 123
36. Wang H., Zhang W., Ni B., et al. Recombination analysis reveals a double recombination event in hepatitis E virus. Virol J: 2010; 7 129
37. Kamar N., Izopet J., Cintas P., et al. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant: 2010; 10 5 1321 1324
38. Lhomme S., Abravanel F., Dubois M., et al. Hepatitis E virus quasispecies and the outcome of acute hepatitis E in solid-organ transplant patients. J Virol: 2012; 86 18 10006 10014
39. Shukla P., Nguyen H. T., Torian U., et al. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc Natl Acad Sci U S A: 2011; 108 6 2438 2443
40. Shukla P., Nguyen H. T., Faulk K., et al. Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination. J Virol: 2012; 86 10 5697 5707
41. Khudyakov YuE, Favorov M. O., Jue D. L., Hine T. K., Fields H. A. Immunodominant antigenic regions in a structural protein of the hepatitis E virus. Virology: 1994; 198 1 390 393
42. Panda S. K., Nanda S. K., Zafrullah M., Ansari I. H., Ozdener M. H., Jameel S. An Indian strain of hepatitis E virus (HEV): cloning, sequence, and expression of structural region and antibody responses in sera from individuals from an area of high-level HEV endemicity. J Clin Microbiol: 1995; 33 10 2653 2659
43. Koonin E. V., Gorbalenya A. E., Purdy M. A., Rozanov M. N., Reyes G. R., Bradley D. W. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses. Proc Natl Acad Sci U S A: 1992; 89 17 8259 8263
44. Ropp S. L., Tam A. W., Beames B., Purdy M., Frey T. K. Expression of the hepatitis E virus ORF1. Arch Virol: 2000; 145 7 1321 1337
45. Sehgal D., Thomas S., Chakraborty M., Jameel S. Expression and processing of the hepatitis E virus ORF1 nonstructural polyprotein. Virol J: 2006; 3 38
46. Ansari I. H., Nanda S. K., Durgapal H., et al. Cloning, sequencing, and expression of the hepatitis E virus (HEV) nonstructural open reading frame 1 (ORF1). J Med Virol: 2000; 60 3 275 283
47. Ahola T., Kääriäinen L. Reaction in alphavirus mRNA capping: formation of a covalent complex of nonstructural protein nsP1 with 7-methyl-GMP. Proc Natl Acad Sci U S A: 1995; 92 2 507 511
48. Magden J., Takeda N., Li T., et al. Virus-specific mRNA capping enzyme encoded by hepatitis E virus. J Virol: 2001; 75 14 6249 6255
49. Karpe Y. A., Lole K. S. RNA 5′-triphosphatase activity of the hepatitis E virus helicase domain. J Virol: 2010; 84 18 9637 9641
50. Zhang M., Purcell R. H., Emerson S. U. Identification of the 5′ terminal sequence of the SAR-55 and MEX-14 strains of hepatitis E virus and confirmation that the genome is capped. J Med Virol: 2001; 65 2 293 295
51. Pichlmair A., Schulz O., Tan C. P., et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science: 2006; 314 5801 997 1001
52. Suppiah S., Zhou Y., Frey T. K. Lack of processing of the expressed ORF1 gene product of hepatitis E virus. Virol J: 2011; 8 245
53. Karpe Y. A., Lole K. S. Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease. J Gen Virol: 2011; 92 Pt 9 2088 2092
54. Karpe Y. A., Meng X. J. Hepatitis E virus replication requires an active ubiquitin-proteasome system. J Virol: 2012; 86 10 5948 5952
55. Karpe Y. A., Lole K. S. NTPase and 5′ to 3′ RNA duplex-unwinding activities of the hepatitis E virus helicase domain. J Virol: 2010; 84 7 3595 3602
56. Agrawal S., Gupta D., Panda S. K. The 3′ end of hepatitis E virus (HEV) genome binds specifically to the viral RNA-dependent RNA polymerase (RdRp). Virology: 2001; 282 1 87 101
57. Rehman S., Kapur N., Durgapal H., Panda S. K. Subcellular localization of hepatitis E virus (HEV) replicase. Virology: 2008; 370 1 77 92
58. Aguiar R. C., Takeyama K., He C., Kreinbrink K., Shipp M. A. B-aggressive lymphoma family proteins have unique domains that modulate transcription and exhibit poly(ADP-ribose) polymerase activity. J Biol Chem: 2005; 280 40 33756 33765
59. Salonen A., Ahola T., Kääriäinen L. Viral RNA replication in association with cellular membranes. Curr Top Microbiol Immunol: 2005; 285 139 173
60. Snijder E. J., Bredenbeek P. J., Dobbe J. C., et al. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol: 2003; 331 5 991 1004
61. Egloff M. P., Malet H., Putics A., et al. Structural and functional basis for ADP-ribose and poly(ADP-ribose) binding by viral macro domains. J Virol: 2006; 80 17 8493 8502
62. Neuvonen M., Ahola T. Differential activities of cellular and viral macro domain proteins in binding of ADP-ribose metabolites. J Mol Biol: 2009; 385 1 212 225
63. Purdy M. A., Lara J., Khudyakov Y. E. The hepatitis E virus polyproline region is involved in viral adaptation. PLoS ONE: 2012; 7 4 e35974
64. Purdy M. A. Evolution of the hepatitis E virus polyproline region: order from disorder. J Virol: 2012; 86 18 10186 10193
65. Jameel S., Zafrullah M., Ozdener M. H., Panda S. K. Expression in animal cells and characterization of the hepatitis E virus structural proteins. J Virol: 1996; 70 1 207 216
66. Zafrullah M., Ozdener M. H., Kumar R., Panda S. K., Jameel S. Mutational analysis of glycosylation, membrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein. J Virol: 1999; 73 5 4074 4082
67. Graff J., Zhou Y. H., Torian U., et al. Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles. J Virol: 2008; 82 3 1185 1194
68. Yamada K., Takahashi M., Hoshino Y., et al. Construction of an infectious cDNA clone of hepatitis E virus strain JE03-1760F that can propagate efficiently in cultured cells. J Gen Virol: 2009; 90 Pt 2 457 462
69. Jiménez de Oya N., Escribano-Romero E., Blázquez A. B., et al. Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses. J Virol: 2012; 86 15 7880 7886
70. Li T. C., Yamakawa Y., Suzuki K., et al. Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol: 1997; 71 10 7207 7213
71. Robinson R. A., Burgess W. H., Emerson S. U., et al. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. Protein Expr Purif: 1998; 12 1 75 84
72. Xing L., Kato K., Li T., et al. Recombinant hepatitis E capsid protein self-assembles into a dual-domain T = 1 particle presenting native virus epitopes. Virology: 1999; 265 1 35 45
73. Li S. W., Zhang J., He Z. Q., et al. Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid. J Biol Chem: 2005; 280 5 3400 3406
74. Yamashita T., Mori Y., Miyazaki N., et al. Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc Natl Acad Sci U S A: 2009; 106 31 12986 12991
75. Guu T. S., Liu Z., Ye Q., et al. Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc Natl Acad Sci U S A: 2009; 106 31 12992 12997
76. Mori Y., Matsuura Y. Structure of hepatitis E viral particle. Virus Res: 2011; 161 1 59 64
77. Zhang J. Z., Ng M. H., Xia N. S., et al. Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein. J Med Virol: 2001; 64 2 125 132
78. Li S. W., Zhang J., Li Y. M., et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine: 2005; 23 22 2893 2901
79. Li S., Tang X., Seetharaman J., et al. Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction. PLoS Pathog: 2009; 5 8 e1000537
80. Schofield D. J., Glamann J., Emerson S. U., Purcell R. H. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. J Virol: 2000; 74 12 5548 5555
81. Meng J., Dai X., Chang J. C., et al. Identification and characterization of the neutralization epitope(s) of the hepatitis E virus. Virology: 2001; 288 2 203 211
82. Zhou Y. H., Purcell R. H., Emerson S. U. An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4. Vaccine: 2004; 22 20 2578 2585
83. Shrestha M. P., Scott R. M., Joshi D. M., et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med: 2007; 356 9 895 903
84. Zhu F. C., Zhang J., Zhang X. F., et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet: 2010; 376 9744 895 902
85. Xing L., Wang J. C., Li T. C., et al. Spatial configuration of hepatitis E virus antigenic domain. J Virol: 2011; 85 2 1117 1124
86. Li T. C., Suzaki Y., Ami Y., Dhole T. N., Miyamura T., Takeda N. Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles. Vaccine: 2004; 22 3-4 370 377
87. Sanford B. J., Opriessnig T., Kenney S. P., Dryman B. A., Córdoba L., Meng X. J. Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs. Vaccine: 2012; 30 44 6249 6255
88. He S., Miao J., Zheng Z., et al. Putative receptor-binding sites of hepatitis E virus. J Gen Virol: 2008; 89 Pt 1 245 249
89. Zheng Z. Z., Miao J., Zhao M., et al. Role of heat-shock protein 90 in hepatitis E virus capsid trafficking. J Gen Virol: 2010; 91 Pt 7 1728 1736
90. Kalia M., Chandra V., Rahman S. A., Sehgal D., Jameel S. Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection. J Virol: 2009; 83 24 12714 12724
91. Kalia M., Jameel S. Virus entry paradigms. Amino Acids: 2011; 41 5 1147 1157
92. Surjit M., Jameel S., Lal S. K. Cytoplasmic localization of the ORF2 protein of hepatitis E virus is dependent on its ability to undergo retrotranslocation from the endoplasmic reticulum. J Virol: 2007; 81 7 3339 3345
93. John L., Thomas S., Herchenröder O., Pützer B. M., Schaefer S. Hepatitis E virus ORF2 protein activates the pro-apoptotic gene CHOP and anti-apoptotic heat shock proteins. PLoS ONE: 2011; 6 9 e25378
94. Surjit M., Varshney B., Lal S. K. The ORF2 glycoprotein of hepatitis E virus inhibits cellular NF-κB activity by blocking ubiquitination mediated proteasomal degradation of IκBα in human hepatoma cells. BMC Biochem: 2012; 13 1 7
95. Emerson S. U., Nguyen H., Torian U., Purcell R. H. ORF3 protein of hepatitis E virus is not required for replication, virion assembly, or infection of hepatoma cells in vitro. J Virol: 2006; 80 21 10457 10464
96. Graff J., Nguyen H., Yu C., et al. The open reading frame 3 gene of hepatitis E virus contains a cis-reactive element and encodes a protein required for infection of macaques. J Virol: 2005; 79 11 6680 6689
97. Zafrullah M., Ozdener M. H., Panda S. K., Jameel S. The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton. J Virol: 1997; 71 12 9045 9053
98. Chandra V., Kar-Roy A., Kumari S., Mayor S., Jameel S. The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response. J Virol: 2008; 82 14 7100 7110
99. Kannan H., Fan S., Patel D., Bossis I., Zhang Y. J. The hepatitis E virus open reading frame 3 product interacts with microtubules and interferes with their dynamics. J Virol: 2009; 83 13 6375 6382
100. Kar-Roy A., Korkaya H., Oberoi R., Lal S. K., Jameel S. The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase. J Biol Chem: 2004; 279 27 28345 28357
101. Korkaya H., Jameel S., Gupta D., et al. The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPK. J Biol Chem: 2001; 276 45 42389 42400
102. Moin S. M., Panteva M., Jameel S. The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death. J Biol Chem: 2007; 282 29 21124 21133
103. Chandra V., Kalia M., Hajela K., Jameel S. The ORF3 protein of hepatitis E virus delays degradation of activated growth factor receptors by interacting with CIN85 and blocking formation of the Cbl-CIN85 complex. J Virol: 2010; 84 8 3857 3867
104. Taneja S., Sen S., Gupta V. K., Aggarwal R., Jameel S. Plasma and urine biomarkers in acute viral hepatitis E. Proteome Sci: 2009; 7 39
105. Tyagi S., Surjit M., Roy A. K., Jameel S., Lal S. K. The ORF3 protein of hepatitis E virus interacts with liver-specific alpha1-microglobulin and its precursor alpha1-microglobulin/bikunin precursor (AMBP) and expedites their export from the hepatocyte. J Biol Chem: 2004; 279 28 29308 29319
106. Tyagi S., Surjit M., Lal S. K. The 41-amino-acid C-terminal region of the hepatitis E virus ORF3 protein interacts with bikunin, a kunitz-type serine protease inhibitor. J Virol: 2005; 79 18 12081 12087
107. Ratra R., Kar-Roy A., Lal S. K. The ORF3 protein of hepatitis E virus interacts with hemopexin by means of its 26 amino acid N-terminal hydrophobic domain II. Biochemistry: 2008; 47 7 1957 1969
108. Ratra R., Kar-Roy A., Lal S. K. ORF3 protein of hepatitis E virus interacts with the Bbeta chain of fibrinogen resulting in decreased fibrinogen secretion from HuH-7 cells. J Gen Virol: 2009; 90 Pt 6 1359 1370
109. Surjit M., Oberoi R., Kumar R., Lal S. K. Enhanced alpha1 microglobulin secretion from hepatitis E virus ORF3-expressing human hepatoma cells is mediated by the tumor susceptibility gene 101. J Biol Chem: 2006; 281 12 8135 8142
110. Moin S. M., Chandra V., Arya R., Jameel S. The hepatitis E virus ORF3 protein stabilizes HIF-1alpha and enhances HIF-1-mediated transcriptional activity through p300/CBP. Cell Microbiol: 2009; 11 9 1409 1421
111. Chandra V., Holla P., Ghosh D., Chakrabarti D., Padigaru M., Jameel S. The hepatitis E virus ORF3 protein regulates the expression of liver-specific genes by modulating localization of hepatocyte nuclear factor 4. PLoS ONE: 2011; 6 7 e22412
112. Takahashi M., Yamada K., Hoshino Y., et al. Monoclonal antibodies raised against the ORF3 protein of hepatitis E virus (HEV) can capture HEV particles in culture supernatant and serum but not those in feces. Arch Virol: 2008; 153 9 1703 1713
113. Emerson S. U., Nguyen H. T., Torian U., Burke D., Engle R., Purcell R. H. Release of genotype 1 hepatitis E virus from cultured hepatoma and polarized intestinal cells depends on open reading frame 3 protein and requires an intact PXXP motif. J Virol: 2010; 84 18 9059 9069
114. Nagashima S., Takahashi M., Jirintai, et al. A PSAP motif in the ORF3 protein of hepatitis E virus is necessary for virion release from infected cells. J Gen Virol: 2011; 92 Pt 2 269 278
115. Nagashima S., Takahashi M., Jirintai S., et al. Tumour susceptibility gene 101 and the vacuolar protein sorting pathway are required for the release of hepatitis E virions. J Gen Virol: 2011; 92 (Pt 12): 2838 2848
116. Kenney S. P., Pudupakam R. S., Huang Y. W., Pierson F. W., LeRoith T., Meng X. J. The PSAP motif within the ORF3 protein of an avian strain of the hepatitis E virus is not critical for viral infectivity in vivo but plays a role in virus release. J Virol: 2012; 86 10 5637 5646
117. Chen B. J., Lamb R. A. Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology: 2008; 372 2 221 232
118. Reyes G. R., Huang C. C., Tam A. W., Purdy M. A. Molecular organization and replication of hepatitis E virus (HEV). Arch Virol Suppl: 1993; 7 15 25
119. Kapur N., Thakral D., Durgapal H., Panda S. K. Hepatitis E virus enters liver cells through receptor-dependent clathrin-mediated endocytosis. J Viral Hepat: 2012; 19 6 436 448
120. Nanda S. K., Panda S. K., Durgapal H., Jameel S. Detection of the negative strand of hepatitis E virus RNA in the livers of experimentally infected rhesus monkeys: evidence for viral replication. J Med Virol: 1994; 42 3 237 240
121. Williams T. P., Kasorndorkbua C., Halbur P. G., et al. Evidence of extrahepatic sites of replication of the hepatitis E virus in a swine model. J Clin Microbiol: 2001; 39 9 3040 3046
122. Ippagunta S. K., Naik S., Jameel S., Ramana K. N., Aggarwal R. Viral RNA but no evidence of replication can be detected in the peripheral blood mononuclear cells of hepatitis E virus-infected patients. J Viral Hepat: 2011; 18 9 668 672
123. Sriram B., Thakral D., Panda S. K. Targeted cleavage of hepatitis E virus 3′ end RNA mediated by hammerhead ribozymes inhibits viral RNA replication. Virology: 2003; 312 2 350 358
124. Huang F., Zhou J., Yang Z., et al. RNA interference inhibits hepatitis E virus mRNA accumulation and protein synthesis in vitro. Vet Microbiol: 2010; 142 3-4 261 267
125. Kamar N., Rostaing L., Abravanel F., et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology: 2010; 139 5 1612 1618
126. de Niet A., Zaaijer H. L., ten Berge I., Weegink C. J., Reesink H. W., Beuers U. Chronic hepatitis E after solid organ transplantation. Neth J Med: 2012; 70 6 261 266
127. Pischke S., Stiefel P., Franz B., et al. Chronic hepatitis e in heart transplant recipients. Am J Transplant: 2012; 12 11 3128 3133
128. Gerolami R., Borentain P., Raissouni F., Motte A., Solas C., Colson P. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol: 2011; 52 1 60 62
129. Goyal R., Kumar A., Panda S. K., Paul S. B., Acharya S. K. Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report. Antivir Ther: 2012; 17 6 1091 1096